Claim Missing Document
Check
Articles

Found 12 Documents
Search

Identification Of Escherichia Coli Bacterial Contamination in Home Industry Baby Porridge In The Malang City Area Dafin, Anis Akhwan; Putri, Elsa Mahardika; Prasetyawan, Fendy; Muslikh, Faisal Akhmal; Ma’arif, Burhan; Megawati, Dewi Sinta
International Journal of Contemporary Sciences (IJCS) Vol. 1 No. 1 (2023): November 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijcs.v1i1.7269

Abstract

Growth and development in toddlers is very important, especially the nutritional needs of toddlers. MP-ASI is additional food to provide sufficient nutrition for babies. MP-ASI is divided into two types, namely traditional and industrial. Traditional MP-ASI is baby porridge that is prepared by yourself and sold on the side of the road. Hygiene and sanitation in roadside food can have a negative impact on consumers, especially bacterial contamination of food, one of which is Coliform bacteria, Escherichia Coli, etc. The method for calculating and estimating the number of E. coli bacteria found in chicken meat in this study used the Most Probable Number (MPN). The results showed that of the 4 samples tested, 3 were contaminated with E. Coli bacteria and 1 was negative for E. Coli bacterial contamination
Utilization of Antiviral Medications in COVID-19 Patients with Chronic Kidney Disease in Hospital Saristiana, Yuneka; Prasetyawan, Fendy; Muslikh, Faisal Akhmal; Dhafin, Anis Akhwan; Mildawati, Ratna; Putri, Elsa Mahardika; Raharjo, Susilo Margining
International Journal of Contemporary Sciences (IJCS) Vol. 1 No. 1 (2023): November 2023
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijcs.v1i1.7284

Abstract

The COVID-19 pandemic has presented a substantial global health challenge, affecting diverse patient populations, particularly those with chronic kidney disease. Hospitals are presently dependent on two antiviral medications, favipiravir and remdesivir, to mitigate the impact of this disease on patients with chronic kidney disease. This study aims to evaluate the utilization of favipiravir and remdesivir in COVID-19 patients with chronic kidney disease in a hospital setting. This research will employ a retrospective approach to gather data from the medical records of COVID-19 patients with chronic kidney disease who received treatment with favipiravir or remdesivir in the hospital. Considering the prevalence of favipiravir usage at 64% and remdesivir at 36%, this research aims to provide a comprehensive understanding of the effectiveness and associated risks of toxicity linked to these two medications in COVID-19 patients with chronic kidney disease